Bayer, Janssen facing 5,000 Xarelto lawsuits over severe bleeding episodes linked to bloodthinner drug

by Charles Miller

Bayer and Johnson & Johnson’s Janssen Pharmaceuticals unit are facing more than 5,000 lawsuits filed by patients who suffered severe bleeding or other complications linked to the bloodthinner drug Xarelto. The 5,000 pending Xarelto lawsuits including thousands of complaints that were consolidated in a multidistrict litigation (MDL) in Louisiana and several hundred more lawsuits consolidated as part of a mass tort litigation in Pennsylvania.

In March 2016, the judge who will oversee the federally-filed Xarelto lawsuits in Louisiana selected 40 of these claims for the discovery pool that will be used by lawyers in the case to gather evidence for the first cases that go to trial. The first of the Louisiana Xarelto claims are scheduled to go to trial in early 2017.

The lawsuits against Bayer and Janssen allege that patients who take Xarelto may suffer gastrointestinal bleeding, bleeding that requires a transfusion, and other episodes of severe bleeding. Patients who have filed claims against Bayer and Janssen allege that the two companies failed to warn them about the increased risk of severe and potentially fatal bleeding they could face from taking Xarelto.

Plaintiffs in the lawsuits against the two drugmakers allege that the companies cherry-picked information from pre-market studies for Xarelto to make it appear more safe while failing to fully disclose the risks of the drug to the public. The lawsuits also allege that Bayer and Janssen incorrectly led doctors to believe that follow up blood testing was not necessary for patients taking the drug.

Xarelto was approved by the Food and Drug Administration in 2011 to treat patients at risk of pulmonary embolism or deep vein thrombosis, and to prevent blood clots in patients who had recently undergone hip or knee replacement surgery. Xarelto was intended to replace the drug warfarin as the frontline therapy to prevent blood clots because it supposedly did not require the same level of monitoring from doctors in order to ensure patient safety.

Unlike warfarin, however, there is no readily available antidote to counter Xarelto’s anticoagulant effects. As a result, it may be more difficult to stop severe bleeding episodes in patients who are taking Xarelto, increasing their risk of severe and potentially deadly health consequences.

Pharmaceutical Liability Lawsuits Filed by HO&P

Despite the efforts of the FDA and other federal regulators, thousands of patients are injured every year as a result of side effects from prescription medications. Far too often, the drug industry puts profit ahead of patient interests, disregarding the safety concerns because of the enormous sales that “blockbuster” drugs and medical devices can generate.

If you or a loved one has been injured due to complications caused by a prescription medication, you may be eligible to file a lawsuit against the drug’s manufacturer, as well as the doctor or hospital who prescribed the drug. The first step in taking legal action is to speak with an attorney who can help guide you through the process of filing a claim.

If you or a loved one has been injured as a result of complications from Xarelto or other medications, contact the lawyers at Heygood, Orr & Pearson to learn more about whether you may be eligible to file a case. For a free legal consultation from an attorney and to find out more about filing a lawsuit, please call us toll-free at 1-877-446-9001, or simply follow this link to our free case evaluation form and answer a few simple questions about your case to get started.


Case results depend upon a variety of factors unique to each case. Results of other cases do not guarantee or predict a similar result in any future case.

Charles Attorney Headshot

by Charles Miller

Charles Miller is a licensed attorney and a partner at Heygood, Orr & Pearson. Charles focuses his practice on areas of complex commercial litigation and personal injury litigation.